Abstract
Objective Objective To study the age distribution characteristics of otitis media with effusion in children and provide a basis for the selection of the timing of tympanic membrane perforation repair in children.
Methods A total of 1915 children with otitis media with effusion who visited our hospital from 2017 to 2022 were collected and divided into 4 groups according to age, namely, infant group, preschool group, school-age group and adolescent group, to study the distribution characteristics of the age of onset of children with otitis media with effusion.
Results The peak age of children with otitis media with effusion in the preschool period of 4-6 years old was the peak age of children with otitis media with effusion. The number of visits for otitis media with effusion in children aged 7 years old showed an obvious decline “inflection point”, and the number of visits for otitis media with effusion in adolescent children after the age of 13 years old tended to be stable.
Conclusion The incidence of otitis media with effusion in children decreased significantly after the age of 7, and the number of visits for otitis media with effusion in children aged 13 years was close to that of adults. This conclusion provides a theoretical basis for the timing of tympanic membrane perforation repair in children.
Short summary This study aims to investigate the characteristics of otitis media with effusion otitis media with effusion (OME) in children, focusing on the peak periods for treatment and surgical intervention, the “inflection point” in treatment trends, and the overall changing trends in OME. The findings will provide a foundation for determining the appropriate timing for surgical intervention in pediatric OME cases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Medical Ethics Committee of Henan Provincial People's Hospital. Approval number: 2019PHB109-01.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
There are no sources of financial support or funding.
The authors have no conflicts of interest to disclose.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
